A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis

Clinical trial NCT00380744 · COMPLETED

Trial details

NCT number: NCT00380744
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2005-11-01
Primary completion: 2007-11-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.